» Go to news main
Zebrafish lead Dalhousie researchers to important discoveries in prostate cancer and leukemia
The zebrafish, a four- to six-centimetre minnow, has led researchers to remarkable revelations about the development and treatment of human disease.
These include a surprising discovery about prostate cancer, and a hopeful one for childhood leukemia, in studies led by Dr. Graham Dellaire and Dr. Jason Berman at Dalhousie.
Dr. Dellaire’s main interest is the treatment of solid tumours found in breast, lung and prostate cancer. He sees zebrafish as an important vehicle for developing personalized cancer therapies.
“If we can inject the embryo with cells from a human tumour and then introduce a range of chemotherapy treatments, we can figure out which one works best for a particular patient,” he says.
Read more on Dal News.
Recent News
- Big research, little time: Medical neuroscience student wins 3 Minute Thesis finals
- Black Health Primer aims for inclusive healthcare
- 54th annual event was hosted Feb. 17, 2024, to sold out crowds
- Dalhousie University's Master of Physician Assistant Studies Program
- Association of Faculties of Medicine of Canada recognizes Dalhousie learners, faculty, and staff
- Dal Med student helps African Nova Scotian youth discover a passion for STEM
- New national program supports mental health of doctors and trainees with daily messages
- Dalhousie researchers navigate world of anesthesia in microgravity